Latest filing published 30 Mar 2021 for TFF Pharmaceuticals, Inc., €8.5M.
Filing timeline
BuySaleInsider track record
Lung Therapeutics, Inc.: trading record in brief
Lung Therapeutics, Inc. is a declared insider of TFF Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 4 filings; the first trade dates from 4 December 2020 and the latest from 26 March 2021.
No open-market purchase appears, only 4 sales worth €20.5M. In 2021 alone, the filings show no purchases and 1 sale.
The newest entry dates from 30 March 2021: an open-market sale of €8.5M, in TFF Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lung Therapeutics, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 715,000 shares@ US$14.0041.5% of flowCommon StockSEC:0001213900-21-018561:0
- 500,000 shares@ US$13.8547.6% of flowCommon StockSEC:0001213900-20-041606:0
- 300,000 shares@ US$13.8628.6% of flowCommon StockSEC:0001213900-20-041606:1
- 250,000 shares@ US$13.8623.8% of flowCommon StockSEC:0001213900-20-041606:2
4 of 4 declarations